tirzepatide cardiovascular outcomes trial results july 2025 Will or semaglutide prove effective in primary prevention of disease? Tirzepatide cardiovascular event risk assessment:

For more on TMAO see: Egg Industry Response to Choline & TMAO How to Develop a Healthy Gut Ecosystem How Our Gut Bacteria Can Use Eggs to Accelerate Cancer How to Reduce Your TMAO Levels Can Vegan Fecal Transplants Lower TMAO Levels

Semaglutide Misuse in Atypical Anorexia Nervosa-A Case Report [PMID: 38329147] Laboratory literature summary: Semaglutide Misuse in Atypical Anorexia Nervosa-A Case Report

One study published in The New England Journal of Medicine found that participants who took Semaglutide lost an average of 14.9% of their body weight over a period of one year, compared to 2.4% in the placebo group

IR.KAUMS.MEDNT.REC.1398.088)

Studies revealed that in aged rhesus monkeys (20-26 years), Epithalon increased melatonin levels more than 3-fold compared to baseline, restoring circadian patterns characteristic of younger animals